8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)

A. Boerekamps; T. Vanwolleghem; M. van der Valk; E. Van den Berk Guido; D. Posthouwe; D. Anton; B. V. Hoek; S. Ramsoekh; M. V. Kasteren; J. Schinkel; E. Florence; J. E. Arends; B. Rijnders

doi:10.1016/S0168-8278(18)30457-4

8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)

A. Boerekamps
, T. Vanwolleghem
, M. van der Valk
, E. Van den Berk Guido
, D. Posthouwe
, D. Anton
, B. V. Hoek
, S. Ramsoekh
, M. V. Kasteren
, J. Schinkel
, E. Florence
, J. E. Arends
, B. Rijnders

Research output: Contribution to journal › Meeting abstract in journal

Original language	English
Journal	Journal of Hepatology
Volume	68
Pages (from-to)	S122-S123
Number of pages	2
ISSN	0168-8278
DOIs	https://doi.org/10.1016/S0168-8278(18)30457-4
Publication status	Published - 2018
Event	International Liver Congress (ILC) - Paris, France Duration: 11-Apr-2018 → 15-Apr-2018

Access to Document

10.1016/S0168-8278(18)30457-4

Cite this

Boerekamps, A., Vanwolleghem, T., van der Valk, M., Guido, E. V. D. B., Posthouwe, D., Anton, D., Hoek, B. V., Ramsoekh, S., Kasteren, M. V., Schinkel, J., Florence, E., Arends, J. E., & Rijnders, B. (2018). 8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001). Journal of Hepatology, 68, S122-S123. https://doi.org/10.1016/S0168-8278(18)30457-4

@article{cce313efe0884e8ab77d9f9ad3dd8f7d,

title = "8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)",

author = "A. Boerekamps and T. Vanwolleghem and \{van der Valk\}, M. and Guido, \{E. Van den Berk\} and D. Posthouwe and D. Anton and Hoek, \{B. V.\} and S. Ramsoekh and Kasteren, \{M. V.\} and J. Schinkel and E. Florence and Arends, \{J. E.\} and B. Rijnders",

note = "NPP; International Liver Congress (ILC) ; Conference date: 11-04-2018 Through 15-04-2018",

year = "2018",

doi = "10.1016/S0168-8278(18)30457-4",

language = "English",

volume = "68",

pages = "S122--S123",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

}

Boerekamps, A, Vanwolleghem, T, van der Valk, M, Guido, EVDB, Posthouwe, D, Anton, D, Hoek, BV, Ramsoekh, S, Kasteren, MV, Schinkel, J, Florence, E, Arends, JE & Rijnders, B 2018, '8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)', Journal of Hepatology, vol. 68, pp. S122-S123. https://doi.org/10.1016/S0168-8278(18)30457-4

TY - JOUR

T1 - 8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: a single-arm multicenter phase 3b study (HepNed-001)

AU - Boerekamps, A.

AU - Vanwolleghem, T.

AU - van der Valk, M.

AU - Guido, E. Van den Berk

AU - Posthouwe, D.

AU - Anton, D.

AU - Hoek, B. V.

AU - Ramsoekh, S.

AU - Kasteren, M. V.

AU - Schinkel, J.

AU - Florence, E.

AU - Arends, J. E.

AU - Rijnders, B.

N1 - NPP

PY - 2018

Y1 - 2018

U2 - 10.1016/S0168-8278(18)30457-4

DO - 10.1016/S0168-8278(18)30457-4

M3 - Meeting abstract in journal

SN - 0168-8278

VL - 68

SP - S122-S123

JO - Journal of Hepatology

JF - Journal of Hepatology

T2 - International Liver Congress (ILC)

Y2 - 11 April 2018 through 15 April 2018

ER -